Deliver Your News to the World

CybeRelease: (OTC: MNCL) Prepares for Infomercial into the Multi-Billion Dollar Health and Wellness Marketplace


(CybeRelease, August 28, 2007) - Lake Harmony, Pa. - Martin Nutraceuticals (OTC PK: MNCL) announced that it is undertaking an aggressive media launch in preparation of airing for the much anticipated DRTV (infomercial). The launch will consist of several radio and television appearances by Dr. Tony Martin, author of “Medical Crisis: Secrets your doctor won’t share with you” and the spokesperson for Martin Nutraceuticals. An initial media blitz was announced in previous months; however, the delay in the airing of the infomercial caused a delay in the media blitz as well.

Dr. Martin’s first radio show will be on the Corus Entertainment Network. Corus boasts the strongest collection of radio assets in Canada. These assets include 52 stations clustered in major markets, reaching more people than any other radio group.

Cheryl Gillespie, an interviewer for the nationally syndicated talk show, At Home, on the Corus Entertainment Network has requested to interview Dr. Martin a second time as the first interview eclipsed all of At Home’s expectations and resulted in the show’s highest listener response rates.

Mr. Harvey Panesar, President of Martin Nutraceuticals, enthusiastically reported, “The timing of this second interview on At Home with Cheryl Gillespie is perfect. This additional appearance provides increased exposure to Dr. Martin prior to the launch of the Infomercial featuring his new breakthrough book, ”Medical Crisis: Secrets your Doctor Won’t Share with You“. It is also a very natural follow up to Dr. Martins own radio show ”Be Your Best: Real Nutrition Talk“ which developed a significant market share. Mr. Panesar further stated, ”We are excited that Tony’s message and straight talk about health and nutrition is being so well received by all those who have the opportunity to hear him"

About Martin Nutraceuticals Inc. (MNI)

Martin Nutraceuticals Inc. is a company focused on providing a better health and lifestyle through natural products. MNI’s flagship products include Arthrizyme(TM) for general joint pain, Oxygenol(TM) a powerful anti-oxidant and Maximum Slim(TM) for weight control. MNI’s products can be found on its website at

Arthrizyme(TM) is a unique blend of systemic enzymes proven to rapidly reduce inflammation in joints and muscles. Arthrizyme(TM) is not limited to anti-inflammatory effects; it also assists the body in the healing process by breaking down fibrin in joints and muscles. Arthrizyme(TM) differs from all other natural arthritis remedies and was designed to work for all types of arthritis and in all joints of the body. Arthrizyme(TM) is fast acting, usually improving symptoms within the first few days.

MNI is also in the process of developing an Infomercial for the U.S. market to promote Dr. Anthony Martin’s new best-selling book, “Medical Crisis: Secrets your Doctor Won’t Share with You”. Presales of the book are available at:

To read the complete release, go to

CybeRelease Gainers are NVIDIA Corporation (Nasdaq: NVDA),, Inc. (Nasdaq: BIDU), Whole Foods Market, Inc. (Nasdaq: WFMI), Shanda Interactive Entertainment Limited (Nasdaq: SNDA), DryShips Inc. (Nasdaq: DRYS), NutriSystem Inc (Nasdaq: NTRI) and Cognos Incorporated (Nasdaq: COGN).

CybeRelease Decliners are SanDisk Corporation (Nasdaq: SNDK), Neurochem Inc (Nasdaq: NRMX), Ceragon Networks Ltd. (Nasdaq: CRNT), Varian Semiconductor Equipment Associates, Inc. (Nasdaq: VSEA), Garmin Ltd. (Nasdaq: GRMN), Wynn Resorts, Limited (Nasdaq: WYNN) and Sears Holdings Corporation (Nasdaq: SHLD).

Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor’s reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. A third party has hired and paid CybeRelease $500.00 for the publication of this report. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. We have no ownership of equity, no representation and do no trading of any kind.


This news content may be integrated into any legitimate news gathering and publishing effort. Linking is permitted.

News Release Distribution and Press Release Distribution Services Provided by WebWire.